To ensure the effective involvement of individual experts in joint clinical assessment of medical devices, the JCA Subgroup should specify the information necessary for their identification as early as possible, whenever the Coordination Group recommends selecting a medical device for joint clinical assessment. The HTA secretariat should identify individual experts on the basis of that information.
Recital 12, Regulation (EU) 2025/2086
In forcesince 17 Oct 2025